Updates zur chronisch nichtbakteriellen Osteomyelitis (CNO)

Gabriele Hahn; Christian M. Hedrich

doi:10.1055/a-2198-2295

Arthritis und Rheuma, Inhaltsverzeichnis

Arthritis und Rheuma 2023; 43(06): 393-402
DOI: 10.1055/a-2198-2295

Schwerpunkt

Updates zur chronisch nichtbakteriellen Osteomyelitis (CNO)

Gabriele Hahn

¹Institut und Poliklinik für Diagnostische und Interventionelle Radiologie, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Deutschland

,

Christian M. Hedrich

²Department of Women’s & Children’s Health, Institute of Life Course and Medical Sciences, University of Liverpool & Department of Paediatric Rheumatology, Alder Hey Children’s NHS Foundation Trust Hospital, Liverpool, UK

› Institutsangaben

Abstract

ZUSAMMENFASSUNG

Die chronisch nichtbakterielle Osteomyelitis (CNO) ist eine nicht infektiöse, (auto)-inflammatorische Knochenerkrankung, die zumeist Kinder und Jugendliche betrifft. Das klinische Bild reicht von singulären, manchmal selbstlimitierten Knochenherden bis zu chronisch aktiven oder rekurrierenden multifokalen Verläufen mit Hyperostosen und/oder Frakturen. Wichtige Differenzialdiagnosen beinhalten Infektionen, maligne und benigne Tumoren sowie Stoffwechselerkrankungen. In den letzten Jahren wurden signifikante Fortschritte im Verständnis der molekularen Pathophysiologie gemacht, die das Ansprechen auf Therapien erklären und neue therapeutische Ansatzpunkte ins Spiel bringen. Dieser Artikel fasst neueste Erkenntnisse zusammen und diskutiert das diagnostische und therapeutische Herangehen der Autoren im Kontext der vorliegenden Literatur.

Schlüsselwörter

CNO - CRMO - nichtbakterielle Osteomyelitis - Knochen - Inflammation - Diagnose - Therapie

Volltext

Referenzen

Literatur
1 Jansson A, Renner ED, Ramser J. et al Classification of non-bacterial osteitis: retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatology (Oxford) 2007; 46 (01) 154-160
2 Hedrich CM, Hofmann SR, Pablik J. et al Autoinflammatory bone disorders with special focus on chronic recurrent multifocal osteomyelitis (CRMO). Pediatr Rheumatol Online J 2013; 11 (01) 47
3 Hofmann SR, Kapplusch F, Girschick HJ. et al Chronic Recurrent Multifocal Osteomyelitis (CRMO): Presentation, Pathogenesis, and Treatment. Curr Osteoporos Rep 2017; 15 (06) 542-554
4 Zhao DY, McCann L, Hahn G, Hedrich CM. Chronic nonbacterial osteomyelitis (CNO) and chronic recurrent multifocal osteomyelitis (CRMO). J Transl Autoimmun 2021; 04: 100095
5 Hofmann SR, Schnabel A, Rosen-Wolff A. et al Chronic Nonbacterial Osteomyelitis: Pathophysiological Concepts and Current Treatment Strategies. J Rheumatol 2016; 43 (11) 1956-1964
6 Jansson AF, Grote V, Group ES. Nonbacterial osteitis in children: data of a German Incidence Surveillance Study. Acta Paediatr 2011; 100 (08) 1150-1157
7 Walsh P, Manners PJ, Vercoe J. et al Chronic recurrent multifocal osteomyelitis in children: nine years’ experience at a statewide tertiary paediatric rheumatology referral centre. Rheumatology (Oxford) 2015; 54 (09) 1688-1691
8 Zhao Y, Ferguson PJ. Chronic non-bacterial osteomyelitis and autoinflammatory bone diseases. Clin Immunol 2020; 216: 108458
9 Schnabel A, Range U, Hahn G. et al Unexpectedly high incidences of chronic non-bacterial as compared to bacterial osteomyelitis in children. Rheumatol Int 2016; 36 (12) 1737-1745
10 Borzutzky A, Stern S, Reiff A. et al Pediatric chronic nonbacterial osteomyelitis. Pediatrics 2012; 130 (05) e1190-1197
11 d’Adamo AP, Bianco AM, Ferrara G. et al High prevalence of rare FBLIM1 gene variants in an Italian cohort of patients with Chronic Non-bacterial Osteomyelitis (CNO). Pediatr Rheumatol Online J 2020; 18 (01) 55
12 Girschick H, Finetti M, Orlando F. et al The multifaceted presentation of chronic recurrent multifocal osteomyelitis: a series of 486 cases from the Eurofever international registry. Rheumatology (Oxford) 2018; 57 (08) 1504
13 Huber AM, Lam PY, Duffy CM. et al Chronic recurrent multifocal osteomyelitis: clinical outcomes after more than five years of follow-up. J Pediatr 2002; 141 (02) 198-203
14 Kaiser D, Bolt I, Hofer M. et al Chronic nonbacterial osteomyelitis in children: a retrospective multicenter study. Pediatr Rheumatol Online J 2015; 13: 25
15 Wipff J, Costantino F, Lemelle I. et al A large national cohort of French patients with chronic recurrent multifocal osteitis. Arthritis Rheumatol 2015; 67 (04) 1128-1137
16 Ziobrowska-Bech A, Fiirgaard B, Heuck C. et al Ten-year review of Danish children with chronic non-bacterial osteitis. Clin Exp Rheumatol 2013; 31 (06) 974-979
17 Bhat CS, Anderson C, Harbinson A. et al Chronic non bacterial osteitis – a multicentre study. Pediatr Rheumatol Online J 2018; 16 (01) 74
18 Hospach T, Langendoerfer M, von Kalle T. et al Spinal involvement in chronic recurrent multifocal osteomyelitis (CRMO) in childhood and effect of pamidronate. Eur J Pediatr 2010; 169 (09) 1105-1111
19 Schnabel A, Nashawi M, Anderson C. et al TNF-inhibitors or bisphosphonates in chronic nonbacterial osteomyelitis? – Results of an international retrospective multicenter study. Clin Immunol 2022; 238: 109018
20 Schnabel A, Range U, Hahn G. et al Treatment Response and Longterm Outcomes in Children with Chronic Nonbacterial Osteomyelitis. J Rheumatol 2017; 44 (07) 1058-1065
21 Beretta-Piccoli BC, Sauvain MJ, Gal I. et al Synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome in childhood: a report of ten cases and review of the literature. Eur J Pediatr 2000; 159 (08) 594-601
22 Kerrison C, Davidson JE, Cleary AG, Beresford MW. Pamidronate in the treatment of childhood SAPHO syndrome. Rheumatology (Oxford) 2004; 43 (10) 1246-1251
23 Schilling F, Marker-Hermann E. [Chronic recurrent multifocal osteomyelitis in association with chronic inflammatory bowel disease: entheropathic CRMO]. Z Rheumatol 2003; 62 (06) 527-538
24 Skrabl-Baumgartner A, Singer P, Greimel T. et al Chronic non-bacterial osteomyelitis: a comparative study between children and adults. Pediatr Rheumatol Online J 2019; 17 (01) 49
25 Valls-Roc M, Sanmarti M, Salles M. et al SAPHO syndrome and pamidronate revisited. Rheumatology (Oxford) 2005; 44 (01) 137 author reply 138
26 Dagan O, Barak Y, Metzker A. Pyoderma gangrenosum and sterile multifocal osteomyelitis preceding the appearance of Takayasu arteritis. Pediatr Dermatol 1995; 12 (01) 39-42
27 Job-Deslandre C, Krebs S, Kahan A. Chronic recurrent multifocal osteomyelitis: five-year outcomes in 14 pediatric cases. Joint Bone Spine 2001; 68 (03) 245-251
28 Pelkonen P, Ryoppy S, Jaaskelainen J. et al Chronic osteomyelitislike disease with negative bacterial cultures. Am J Dis Child 1988; 142 (11) 1167-1173
29 Hedrich CM, Bream JH. Cell type-specific regulation of IL-10 expression in inflammation and disease. Immunol Res 2010; 47 1–3 185-206
30 Hofmann SR, Kubasch AS, Ioannidis C. et al Altered expression of IL-10 family cytokines in monocytes from CRMO patients result in enhanced IL-1beta expression and release. Clin Immunol 2015; 161 (02) 300-307
31 Hofmann SR, Morbach H, Schwarz T. et al Attenuated TLR4/MAPK signaling in monocytes from patients with CRMO results in impaired IL-10 expression. Clin Immunol 2012; 145 (01) 69-76
32 Hofmann SR, Schwarz T, Moller JC. et al Chronic non-bacterial osteomyelitis is associated with impaired Sp1 signaling, reduced IL10 promoter phosphorylation, and reduced myeloid IL-10 expression. Clin Immunol 2011; 141 (03) 317-327
33 Brandt D, Sohr E, Pablik J. et al CD14(+) monocytes contribute to inflammation in chronic nonbacterial osteomyelitis (CNO) through increased NLRP3 inflammasome expression. Clin Immunol 2018; 196: 77-84
34 Krawiec P, Pawlowska-Kamieniak A, Pac-Kozuchowska E. Interleukin 10 and interleukin 10 receptor in paediatric inflammatory bowel disease: from bench to bedside lesson. J Inflamm (Lond) 2021; 18 (01) 13
35 Kuhn R, Lohler J, Rennick D. et al Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75 (02) 263-274
36 Zhu L, Shi T, Zhong C. et al IL-10 and IL-10 Receptor Mutations in Very Early Onset Inflammatory Bowel Disease. Gastroenterology Res 2017; 10 (02) 65-69
37 Greenhill CJ, Jones GW, Nowell MA. et al Interleukin-10 regulates the inflammasome-driven augmentation of inflammatory arthritis and joint destruction. Arthritis Res Ther 2014; 16 (04) 419
38 Shi J, Zhao Y, Wang K. et al Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 2015; 526 7575 660-665
39 Kuemmerle-Deschner JB. CAPS – pathogenesis, presentation and treatment of an autoinflammatory disease. Semin Immunopathol 2015; 37 (04) 377-385
40 Scianaro R, Insalaco A, Bracci Laudiero L. et al Deregulation of the IL-1beta axis in chronic recurrent multifocal osteomyelitis. Pediatr Rheumatol Online J 2014; 12: 30
41 Vento-Tormo R, Alvarez-Errico D, Garcia-Gomez A. et al DNA demethylation of inflammasome-associated genes is enhanced in patients with cryopyrin-associated periodic syndromes. J Allergy Clin Immunol 2017; 139 (01) 202-211 e6
42 Cox AJ, Darbro BW, Laxer RM. et al Recessive coding and regulatory mutations in FBLIM1 underlie the pathogenesis of chronic recurrent multifocal osteomyelitis (CRMO). PLoS One 2017; 12 (03) e0169687
43 Xiao G, Cheng H, Cao H. et al Critical role of filamin-binding LIM protein 1 (FBLP-1)/migfilin in regulation of bone remodeling. J Biol Chem 2012; 287 (25) 21450-21460
44 Ghonime MG, Shamaa OR, Das S. et al Inflammasome priming by lipopolysaccharide is dependent upon ERK signaling and proteasome function. J Immunol 2014; 192 (08) 3881-3888
45 O’Leary D, Killeen OG, Wilson AG. Genetics of chronic nonbacterial osteomyelitis in the irish population: no significant association with rare FBLIM1 variants. Pediatr Rheumatol Online J 2021; 19 (01) 32
46 Lorden G, Sanjuan-Garcia I, de Pablo N. et al Lipin-2 regulates NLRP3 inflammasome by affecting P2X7 receptor activation. J Exp Med 2017; 214 (02) 511-528
47 Colina M, Pizzirani C, Khodeir M. et al Dysregulation of P2X7 receptor-inflammasome axis in SAPHO syndrome: successful treatment with anakinra. Rheumatology (Oxford) 2010; 49 (07) 1416-1418
48 Ferrari D, Pizzirani C, Adinolfi E. et al The P2X7 receptor: a key player in IL-1 processing and release. J Immunol 2006; 176 (07) 3877-3883
49 Piccini A, Carta S, Tassi S. et al ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way. Proc Natl Acad Sci U S A 2008; 105 (23) 8067-8072
50 Charras A Hofmann SR, Cox A. et al Damaging variants in P2X7R associate with Chronic Nonbacterial Osteomyelitis (CNO). Archives of Disease in Childhood 2022; 107: A260
51 Kular J, Tickner J, Chim SM, Xu J. An overview of the regulation of bone remodelling at the cellular level. Clin Biochem 2012; 45 (12) 863-873
52 Zhu S, Liu M, Bennett S. et al The molecular structure and role of CCL2 (MCP-1) and C-C chemokine receptor CCR2 in skeletal biology and diseases. J Cell Physiol 2021; 236 (10) 7211-7222
53 Hofmann SR, Bottger F, Range U. et al Serum Interleukin-6 and CCL11/Eotaxin May Be Suitable Biomarkers for the Diagnosis of Chronic Nonbacterial Osteomyelitis. Front Pediatr 2017; 05: 256
54 Zhao Y, Wu EY, Oliver MS. et al Consensus Treatment Plans for Chronic Nonbacterial Osteomyelitis Refractory to Nonsteroidal Antiinflammatory Drugs and/or With Active Spinal Lesions. Arthritis Care Res (Hoboken) 2018; 70 (08) 1228-1237
55 Roderick MR, Shah R, Rogers V. et al Chronic recurrent multifocal osteomyelitis (CRMO) – advancing the diagnosis. Pediatr Rheumatol Online J 2016; 14 (01) 47
56 Reiser C, Klotsche J, Hospach A. et al First-year follow-up of children with chronic nonbacterial osteomyelitis-an analysis of the German National Pediatric Rheumatologic Database from 2009 to 2018. Arthritis Res Ther 2021; 23 (01) 281
57 Hofmann SR, Kubasch AS, Range U. et al Serum biomarkers for the diagnosis and monitoring of chronic recurrent multifocal osteomyelitis (CRMO). Rheumatol Int 2016; 36 (06) 769-779
58 Bjorkstén B, Boquist L. Histopathological aspects of chronic recurrent multifocal osteomyelitis. J Bone Joint Surg Br 1980; 62 (03) 376-380
59 Chow LT, Griffith JF, Kumta SM, Leung PC. Chronic recurrent multifocal osteomyelitis: a great clinical and radiologic mimic in need of recognition by the pathologist. APMIS 1999; 107 (04) 369-379
60 Girschick HJ, Huppertz HI, Harmsen D. et al Chronic recurrent multifocal osteomyelitis in children: diagnostic value of histopathology and microbial testing. Hum Pathol 1999; 30 (01) 59-65
61 Falip C, Alison M, Boutry N. et al Chronic recurrent multifocal osteomyelitis (CRMO): a longitudinal case series review. Pediatr Radiol 2013; 43 (03) 355-375
62 Khanna G, Sato TS, Ferguson P. Imaging of chronic recurrent multifocal osteomyelitis. Radiographics 2009; 29 (04) 1159-1177
63 Morbach H, Schneider P, Schwarz T. et al Comparison of magnetic resonance imaging and 99mTechnetium-labelled methylene diphosphonate bone scintigraphy in the initial assessment of chronic non-bacterial osteomyelitis of childhood and adolescents. Clin Exp Rheumatol 2012; 30 (04) 578-582
64 Arnoldi AP, Schlett CL, Douis H. et al Whole-body MRI in patients with Non-bacterial Osteitis: Radiological findings and correlation with clinical data. Eur Radiol 2017; 27 (06) 2391-2399
65 Fritz J, Tzaribatchev N, Claussen CD. et al Chronic recurrent multifocal osteomyelitis: comparison of whole-body MR imaging with radiography and correlation with clinical and laboratory data. Radiology 2009; 252 (03) 842-851
66 Zhao Y, Sato TS, Nielsen SM. et al Development of a Scoring Tool for Chronic Nonbacterial Osteomyelitis Magnetic Resonance Imaging and Evaluation of its Interrater Reliability. J Rheumatol 2020; 47 (05) 739-747
67 Capponi M, Pires Marafon D, Rivosecchi F. et al Assessment of disease activity using a whole-body MRI derived radiological activity index in chronic nonbacterial osteomyelitis. Pediatr Rheumatol Online J 2021; 19 (01) 123
68 Beck C, Morbach H, Beer M. et al Chronic nonbacterial osteomyelitis in childhood: prospective follow-up during the first year of anti-inflammatory treatment. Arthritis Res Ther 2010; 12 (02) R74
69 Batu ED, Ergen FB, Gulhan B. et al Etanercept treatment in five cases of refractory chronic recurrent multifocal osteomyelitis (CRMO). Joint Bone Spine 2015; 82 (06) 471-473
70 Eleftheriou D, Gerschman T, Sebire N. et al Biologic therapy in refractory chronic non-bacterial osteomyelitis of childhood. Rheumatology (Oxford) 2010; 49 (08) 1505-1512
71 Gleeson H, Wiltshire E, Briody J. et al Childhood chronic recurrent multifocal osteomyelitis: pamidronate therapy decreases pain and improves vertebral shape. J Rheumatol 2008; 35 (04) 707-712
72 Miettunen PM, Wei X, Kaura D. et al Dramatic pain relief and resolution of bone inflammation following pamidronate in 9 pediatric patients with persistent chronic recurrent multifocal osteomyelitis (CRMO). Pediatr Rheumatol Online J 2009; 07: 2
73 Roderick M, Shah R, Finn A, Ramanan AV. Efficacy of pamidronate therapy in children with chronic non-bacterial osteitis: disease activity assessment by whole body magnetic resonance imaging. Rheumatology (Oxford) 2014; 53 (11) 1973-1976
74 Simm PJ, Allen RC, Zacharin MR. Bisphosphonate treatment in chronic recurrent multifocal osteomyelitis. J Pediatr 2008; 152 (04) 571-575
75 Brody M, Bohm I, Bauer R. Mechanism of action of methotrexate: experimental evidence that methotrexate blocks the binding of interleukin 1 beta to the interleukin 1 receptor on target cells. Eur J Clin Chem Clin Biochem 1993; 31 (10) 667-674
76 Acierno S, Angrisani F, Marino A. et al Canakinumab treatment in a young girl with refractory chronic recurrent multifocal osteomyelitis associated with pyoderma gangrenosum. Int J Rheum Dis 2022; 25 (11) 1333-1338
77 van Beek ER, Cohen LH, Leroy IM. et al Differentiating the mechanisms of antiresorptive action of nitrogen containing bisphosphonates. Bone 2003; 33 (05) 805-811
78 Kuemmerle-Deschner JB, Welzel T, Hoertnagel K. et al New variant in the IL1RN-gene (DIRA) associated with late-onset, CRMO-like presentation. Rheumatology (Oxford) 2020; 59 (11) 3259-3263
79 Pardeo M, Pires Marafon D, Messia V. et al Anakinra in a Cohort of Children with Chronic Nonbacterial Osteomyelitis. J Rheumatol 2017; 44 (08) 1231-1238
80 Wendling D, Prati C, Aubin F. Anakinra treatment of SAPHO syndrome: short-term results of an open study. Ann Rheum Dis 2012; 71 (06) 1098-1100
81 Oliver M, Jayatilleke A, Wu E. et al Establishing core domain sets for Chronic Nonbacterial Osteomyelitis (CNO) and Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis (SAPHO): A report from the OMERACT 2020 special interest group. Semin Arthritis Rheum 2021; 51 (04) 957-961
82 Hedrich CM, Beresford MW, Dedeoglu F. et al Gathering expert consensus to inform a proposed trial in chronic nonbacterial osteomyelitis (CNO). Clin Immunol 2023; 251: 109344